US 2015/008O352 A1 AQUEOUS POLYURETHANE DISPERSION IN THE TREATMENT OF ACNE
0001. The present invention describes a surprising effect of an aqueous polyurethane dispersion on the efficacy of active ingredients in the anti-acne treatment. The aqueous polyurethane dispersion was able to reduce irritation and Substantially enhance efficacy of the Salicylic acid and/or salicylic acid derivative in the topical anti-acne serum. 0002 The use of the variety of active ingredients in cos metic and OTC (Over-the-Counter) products had become a necessity in order to achieve a wide range of cosmetic and therapeutical effects to satisfy as ever more educated and demanding consumer base. Most of these active ingredients, Such as vitamins, AHAs, enzymes and plant extracts are known for their sensitivity to anti-oxidants, light and water. Many actives used in OTC products, such as Salicylic acid, benzoyl peroxide, retinoids, at the efficacious levels are harsh for sensitive and mature skin, causing irritation, burning sen sation and excessive dryness. Formulating with those actives presents another challenge of maintaining efficacy of these actives over a prolonged period ensuring its long-lasting effect in the topical application. 0003 Various encapsulating techniques and delivery sys tems are proposed to mediate either preservation of actives or their efficacy enhancement. 0004 Specifically, the use of polymers to control delivery of actives and/or to modify treated Surfaces for enhancing efficacy of actives are described in the prior art. 0005 P. Thau in "Controlled delivery and enhancement of Topical Activity of salicylic Acid', in Delivery Systems Handbook for Personal care and Cosmetic Products, MR Rosen, ed. William Andrew, Inc., p. 873-880, reviews contem porary technologies and vehicles to modify delivery and activity of salicylic acid. Among delivery technologies cat egories, one of the polymeric complexation methods is described as using a low molecular weight PEG-8/SMDI copolymers, number-average molecular weight 1,800 g/mol (polyurethane oligomers) that associate with Stratum cor neum, thus increasing deposition of salicylic acid in the upper layers of stratum corneum, which provides potential for increased keratolytic activity. Further, this technology Sug gests a decrease of the permeation of Salicylic acid through pigskin via binding of salicylic acid to the oligomer which is a critical for altering of salicylic acid permeation kinetics. 0006 Most encapsulating or polymer entrapment tech nologies involve a release mechanism through a combination offriction upon application to skin and controlled diffusion of salicylic acid from the various types of polymeric shells. These types of technology are often offered in a form of free powder. 0007 U.S. Pat. No. 8,039,020 B2 teaches encapsulating technique that emphasizes the core-shell structure of the cap Sule containing active ingredient. The invention focuses on preserving unstable active ingredients, such as benzoyl per oxide, and on Stabilizing cosmetic formulation. 0008 U.S. Pat. No. 7, 166, 235 describes the use of silox ane polymers with a pendant carboxyl groups for hydropho bically modifying cationic Surfaces and possibly acting as carriers to deposit actives improving their retention and effi cacy. 0009 U.S. Pat. No. 8,017,150 describes a PO-based poly mers and their blend with cellulosic polymers that form a uniformed film which facilitates an even distribution of actives and prevents their self-agglomeration. The patent Mar. 19, 2015 teaches an importance of film's uniformity and even distri bution of drugs or actives in it for achieving maximum drug efficacy. The proposed films are water soluble and hydro philic. The films are used in a dry form to deliver actives or drugs as an alternative to tablets. (0010 EP 0998 914 A1 describes compositions for enhancing and regulating the penetration of topical skin agents into the epidermal and dermal layers of the skin com prise at least one active ingredient which is hydrophilic or hydrophobic, a polymeric emulsifier and, alternatively, a Sugar or a polyoxyethylene alcohol. The compositions are mild and non-irritating despite the increased penetration of topical active agents. (0011 WO 1999/047 072 A1 describes new hydrophilic polyether polyurethane polymers containing carboxylic acid in diol component, having good adhesion, slip and strength. Claims an article of manufacture comprising a substrate car rying a layer of (I) and an active agent (A) selected from pharmacologically active agents. The articles are medical devices, adsorbents, gloves and body implants. (0012 U.S. Pat. No. 6,177,068 B1 teaches about produc tion of cross-linked vinylamide polymer emulsion, for topical cosmetic applications, involves mixing vinylamide polymer in oil solvent, free radical initiator, water and cosmetic agent under specific condition (0013 US 2011/0076243 A1 discloses are hydrophilic polymers such as polysaccharides, including hyaluronic acid, modified by reaction with epoxy-functional-silicones. Hydrophobic silicon, which contains chemically active groups covalently attach to the backbone of the hydrophilic polymer and gives these new, modified polymers the ability to dissolve hydrophobic compounds including oils, drugs, and Vitamins, while maintaining the hydrophilic properties and benefits of the unmodified polymer. With respect to topical applications these polymers Substantially increase the stabil ity of formulations and provide for ease of preparation. The products can be used for various applications including cos metic, medical, and drug delivery applications. (0014 US 2010/0008884A1 describes the process of pro ducing a hydrophobically modified polymer that is prepared by incorporating hydrophobic moieties into a polymer com posed acrylamide, cationic monomers and optionally anionic monomers. The composition including hydrophobically modified polyacrylamide that enhances properties such as creaminess, slip, feel, Viscosity and moisturization depending on the type of hydrophobic moiety incorporated into the polymer. 0015 The use of salicylic acid in the treatment of common or teen acne is known. For example, U.S. Pat. No. 4, 665, 063 describes the use of topically applied aspirin (acetyl salicylic acid) for treating common acne; and U.S. Pat. No. 4, 891.227 describes the use of pads for applying anti-acne products containing salicylic acid for oily skin. These patents describe state-of-art compositions which emphasize aggressive chemical and physical treatment Suitable for teen acne, with out addressing the suitability for adult acne and/or the need for mildness. 0016 U.S. Pat. No. 4, 800, 197 describes a combination of salicylic acid and an anionic taurate Surfactant, specifically Sodium methyl cocoyl taurate or sodium methyl oleoyl tau rate. U.S. Pat. No. 5.296.476 describes the specific use of salicylic acid in combination with calcium citrate. Again, these treatment modalities are designed for aggressive, physi cal cleansing, which assumes that the individual indicators are normal, young and oily skin. 0017 U.S. Pat. No. 5,569,651 teaches the use of a salicylic acid cream and lotions whose pH is adjusted to from about 3.8 to 4.5 using ammonium hydroxide. U.S. Pat. No. 5,871,764 discloses a salicylic acid powder formulation having a pH of from about 3 to about 4. U.S. Pat. No. 5,612,324 discloses salicylic acid solutions, gels and pads having a pH of from about 2 to about 6.5. 0018 . Additional examples of salicylic acid compositions wherein pH of the composition was controlled may be found in the following U.S. Pat. No. 5,756,119 (pH of less than 5); U.S. Pat. No. 5,549,888 (pH of 2-5.4); U.S. Pat. No. 4,294, 852 (pH of 2-6.5); U.S. Pat. No. 5,702,688 (pH less than or equal to 4.2); U.S. Pat. No. 4, 800, 197 (pH of 2-3.5); and U.S. Pat. No. 5, . 0019 While many technologies claim to improve deposi tion and retention of salicylic acid on the top layers of stratum corneum, controlling its release and enhancing efficacy, most of these technologies are beneficial only in various degrees of performance, safety, aesthetics and value to the consumerand to the cosmetic formulator. A great majority of the proposed Solutions show advantages in one or in a Subset of the above mentioned properties. 0020. A need for a multifunctional, safe, effective and easy to use delivery system still exists to formulate mild and efficacious cosmetic and OTC products for sophisticated con SUCS. 0021. The present invention describes an aqueous poly urethane film former and the compositions containing Such film former for improving efficacy and reducing irritation of OTC products. A polyurethane polymer used at preferably 0.1 to 15% by weight, more preferably 0.5 to 10% by weight, even more preferably 1.0 to 5.0% by weight, in each case based on the total weight of the composition in the anti-acne composition reduced redness and size of the acne lesion, also improved antiflammatory activity of active ingredients in the formulation. The additional benefits of the film former include its pleasantly natural feel on skin, comfortable wear and non-comedogenic properties. It was demonstrated that the film former alone was capable to boost efficacy of the antiflammatory ingredients in the anti-acne serum. The poly merposes a unique combination of properties that allows for achieving significant difference in performance from the standard anti-acne composition. The polymer is an inert, water dispersible high molecular weight polyurethane that forms exceptionally flexible and clear film. 0022. Thus, the presently claimed invention is in one aspect related to an aqueous composition comprising at least one aqueous polyurethane dispersion and Salicylic acid and/ or at least one salicylic acid derivative. 0023 Preferably the salicylic acid derivative is selected from the group consisting of acetaminosalol, aspirin, bal Salazide, benorylate, calcium acetylsalicylate, diflunisal, fen dosal, gentisic acid, glycol salicylate, imidazole salicylate, lysine acetylsalicylate, mesalamine, morpholine salicylate, 1-naphthyl salicylate, olSalazine, parsalmide, phenyl acetyl salicylate, phenyl salicylate, salicylamide O-acetic acid, Sali cylsulfuric acid, Salsalate, Sodium salicylate and Sulfasala Z10. 0024. As used herein the term "acne' refers to any and all forms of acne as well as acneiform conditions such as, without limitation, folliculitis keratosis pilaris. Acne is a broad clini cal syndrome most frequently occurring at puberty in both Mar. 19, 2015 men and women. It may last through life, and consists of lesions most typically on the face and trunk, and consists of papules, pustules, comedones (open and closed), cysts, and microcysts. 0025 Preferred is the use of a polyurethane or a preferably aqueous dispersion thereof, where the polyurethane is obtain able by reacting one or more water-insoluble, non-water dispersible isocyanate-functional polyurethane prepolymers A) and at least one or more amino-functional compounds B), Such as a primary or secondary diamine, which has at least one ionogenic or ionic group, and the salts thereof. 0026. The present invention thus provides a skin care product, especially an anti-acne treatment comprising at least one polyurethane obtainable by reacting one or more water insoluble, non-water-dispersible, isocyanate-functional polyurethane prepolymers A) with one or more amino-func tional compounds B). 0027. Furthermore, the present invention provides an anti acne treatment composition comprising at least one polyure thane polymer obtainable by reacting one or more isocyanate functional polyurethane prepolymers A) which have neither ionic nor ionogenic groups, with one or more amino-func tional compounds B). 0028. Within the context of the invention, the term "water insoluble, non-water-dispersible polyurethane prepolymer means in particular that the solubility in water of the prepoly mer used according to the invention at 23°C. is less than 10 g/litre, more preferably less than 5 g/litre, and the prepolymer does not produce a sedimentation-stable dispersion in water, in particular deionized water, at 23°. In other words, the prepolymer settles out upon attempting to disperse it in water. 0029 Preferably, the polyurethane prepolymer A) used according to the invention has terminal isocyanate groups, i.e. the isocyanate groups are at the chain ends of the prepolymer. All of the chain ends of a polymer particularly preferably have isocyanate groups. 0030. Furthermore, the polyurethane prepolymer A) used according to the invention preferably has neither ionic nor ionogenic (capable of forming ionic groups) groups, i.e. the content of ionic and ionogenic groups is expediently below 15 millieduivalents per 100 g of polyurethane prepolymer A), preferably below 5 milliequivalents, particularly preferably below 1 milliequivalent and very particularly preferably below 0.1 milliequivalent per 100 g of polyurethane prepoly mer A). 0031. The amino-functional compounds B) are preferably selected from primary and/or secondary amines and/or diamines. In particular, the amino-functional compounds B) include at least one diamine. The amino-functional com pounds B) are preferably selected from amino-functional compounds B2), which have ionic or ionogenic group, and amino-functional compounds B1), which have no ionic or ionogenic group. 0032. In a particularly preferred embodiment of the inven tion, the amino-functional compounds B) include at least one amino-functional compound B2) which has ionic and/or ionogenic (ion-forming) groups. The ionic and/or ionogenic group used is particularly preferably the Sulphonate or the Sulphonic acid group, yet more preferably the Sodium Sulpho nate group.
0033. In a further preferred embodiment of the invention, the amino-functional compounds B) include both amino functional compounds B2) which have ionic and/or iono genic group, and also amino-functional compounds B1) which have no ionic or ionogenic group. 0034. Accordingly, polyurethanes within the context of the invention are polymeric compounds which have at least two, preferably at least three, repeat units containing urethane groups:
-N-I-O-0035. According to the invention, also included are those polyurethanes which, as a result of the preparation, also have repeat units containing urea groups:
as are formed in particular in the reaction of the isocyanate terminated prepolymers A) with the amino-functional com pounds B). 0036. The skin care products according to the invention are preferably water-containing, i.e. aqueous, compositions in which the polyurethane is present in dispersed form, i.e. not in dissolved form. In general, besides any other liquid media which may be present, such as, for example, solvents, water forms the main constituent (>50% by weight) of the disper sion media, based on the total amount of the liquid dispersion media in the cosmetic compositions according to the inven tion, and in some cases also forms the Sole liquid dispersion medium.
0037. The skin care products according to the invention preferably have a content of Volatile organic compounds (VOCs) of less than 80% by weight, more preferably of less than 55% by weight, even more preferably of less than 40% by weight, based on the skin care product. 0038. The aqueous polyurethane dispersions used for the preparation of the skin care products according to the inven tion preferably have a content of volatile organic compounds (VOCs) of less than 10% by weight, more preferably of less than 3% by weight, even more preferably of less than 1% by weight, based on the aqueous polyurethane dispersion. 0039. The content of volatile organic compounds (VOCs) is determined within the context of the present invention in particular by gas chromatographic analysis. 0040. The non-water-soluble and non-water-dispersible, isocyanate-functional polyurethane prepolymers used according to the invention have neither ionic nor ionogenic groups. The insolubility in water and/or lack of dispersibility in water refers to deionized water without the addition of surfactants. Within the context of the present invention this means that the proportion of ionic and/or ionogenic (ion forming) groups, such as, in particular, anionic groups. Such as carboxylate or Sulphonate, or of cationic groups is less than 15 millieduivalents per 100g of polyurethane prepolymer A), preferably less than 5 milliequivalents, particularly prefer ably less than 1 milliequivalent and very particularly prefer ably less than 0.1 milliequivalent per 100 g of polyurethane prepolymer A). 0041. In the case of acidic ionic and/or ionogenic groups, the acid number of the prepolymer is expediently below 30 mg of KOH/g of prepolymer, preferably below 10 mg of KOH?g of prepolymer. The acid number indicates the mass of Mar. 19, 2015 potassium hydroxide in mg which is required to neutralize 1 g of the sample under investigation (measurement in accor dance with DIN EN ISO 211). The neutralized acids, i.e. the corresponding salts, naturally have no acid number or a reduced acid number. According to the invention, the acid number of the corresponding free acid is decisive here. 0042. The prepolymers A) used for the preparation of the polyurethanes are preferably obtainable by reacting one or more polyols selected from the group which consists of poly ether polyols, polycarbonate polyols, polyether polycarbon ate polyols and/or polyester polyols, and polyisocyanates, as is explained in more detail below. 0043. The polyurethanes present in the skin care products according to the invention accordingly comprise, via the pre polymer A), preferably at least one sequence selected from the group which consists of polyether, polycarbonate, poly ether-polycarbonate and polyester sequences. According to the invention, this means in particular that the polyurethanes contain repeat units containing ether groups and/or carbonate groups or ester groups. The polyurethanes can contain, for example, exclusively polyether sequences or exclusively polycarbonate sequences or exclusively polyester sequences. However, they can also have both polyether and polycarbon ate sequences, as are formed, for example, during the prepa ration of polycarbonate polyols using polyetherdiols, as is described in more detail below. In addition, they can have polyether-polycarbonate sequences which arise from the use of polyether-polycarbonate polyols, as described in more detail below.
0044 Particularly preferred polyurethanes are obtained using polymeric polyether polyols and/or polymeric polycar bonate polyols and/or polyether-polycarbonate polyols or polyester polyols, each of which have number-average molecular weights of preferably about 400 to about 6000 g/mol (here and in the case of the molecular weight data below, determined by gel permeation chromatography rela tive to polystyrene standard in tetrahydrofuran at 23° C.). Their use during the preparation of the polyurethanes or poly urethane prepolymers leads, as a result of the reaction with polyisocyanates, to the formation of corresponding polyether and/or polycarbonate and/or polyether-polycarbonate sequences or polyester sequences in the polyurethanes with a corresponding molecular weight of these sequences. Accord ing to the invention, particular preference is given to polyure thanes which are obtained from polymeric polyetherdiols and/or polymeric polycarbonatediols and/or polyether-poly carbonate polyols or polyester polyols with a linear structure. 0045. The polyurethanes according to the invention are preferably linear molecules, but may also be branched, which is less preferred. 0046. The number-average molecular weight of the poly urethanes preferably used according to the invention is, for example, about 1000 to 200000, preferably from 5000 to 150 OOO. 0047. The polyurethanes present in the skin care products according to the invention are added to the specified compo sitions in particular in the form of aqueous dispersions. 0048 Preferred polyurethanes or polyurethane disper sions to be used according to the invention are obtainable by A) preparing isocyanate-functional prepolymers of 0049 A1) organic polyisocyanates, 0050 A2) polymeric polyols, preferably with number average molecular weights of from 400 to 8000 g/mol (here and for the molecular weight data below, deter mined by gel permeation chromatography relative to polystyrene standard in tetrahydrofuranat 23°C.), more preferably 400 to 6000 g/mol and particularly preferably from 600 to 3000 g/mol, and OH functionalities of pref erably 1.5 to 6, more preferably 1.8 to 3, particularly preferably from 1.9 to 2.1, 0051 A3) optionally hydroxy-functional compounds with molecular weights of preferably 62 to 399 g/mol, and 0.052 A4) optionally nonionic hydrophilizing agents, 0053 and B) then reacting some or all of their free NCO groups 0054 with one or more amino-functional compounds B). Such as primary and/or secondary amines and/or diamines.
0055. The polyurethanes used according to the invention are preferably dispersed in water before, during or after step B). 0056. The reaction with a diamine or two or more diamines in step B) particularly preferably takes place with chain extension. In this connection, monofunctional amines can additionally be added as chain terminators to control the molecular weight. 0057. As component B), in particular amines can be used which have no ionic or ionogenic, such as anionically hydro philizing groups (component B1 below)) and it is possible to use amines which have ionic or ionogenic, such as, in par ticular, anionically hydrophilizing groups (component B2 below)). 0058 Preferably, in step B) of the reaction of the prepoly mer, a mixture of component B1) and component B2) is reacted. By using component B1) it is possible to build up a high molar mass without the Viscosity of the previously pre pared isocyanate-functional prepolymer increasing to a degree which would be an obstacle to processing. By using the combination of components B1) and B2) it is possible to achieve an optimum balance between hydrophilicity and chain length and thus establish a pleasant skin feel. 0059. The polyurethanes used according to the invention preferably have anionic groups, preferably Sulphonate groups. These anionic groups are introduced into the poly urethanes used according to the invention via the amine com ponent B2) reacted in step B). The polyurethanes used according to the invention optionally additionally have non ionic components for hydrophilization. Exclusively Sulpho nate groups are particularly preferably present in the polyure thanes used according to the invention for the hydrophilization; these are introduced into the polyurethane via corresponding diamines as component B2). 0060. In order to achieve a good sedimentation stability, the number-average particle size of the special polyurethane dispersions is preferably less than 750 nm, particularly pref erably less than 500 nm, determined by means of laser cor relation spectroscopy following dilution with deionized water (instrument: Malvern Zetasizer 1000, Malvern Inst. Limited). 0061 The solids content of the polyurethane dispersions which is preferably used for preparing the skin care product of the invention is generally 10 to 70% by weight, preferably 30 to 65% by weight, particularly preferably 40 to 60% by weight. The Solids contents are ascertained by heating a weighed sample at 125° C. to constant weight. At constant weight, the Solid-body content is calculated by reweighing the sample. 0065 Besides the aforementioned polyisocyanates, it is also possible to use modified diisocyanates which have a functionality of >2 with uretdione, isocyanurate, urethane, allophanate, biuret, iminooxadiazinedione or oxadiazinetri one structure, and also mixtures of these proportionately. 0066. They are preferably polyisocyanates or polyisocy anate mixtures of the type specified above with exclusively aliphatically or cycloaliphatically bonded isocyanate groups or mixtures of these and an average NCO functionality of the mixture of from 2 to 4, preferably 2 to 2.6 and particularly preferably 2 to 2.4, very particularly preferably 2. 0067 Hexamethylene diisocyanate, isophorone diisocy anate or the isomeric bis(4,4'-isocyanatocyclohexyl)meth anes, and mixtures of the aforementioned diisocyanates are particularly preferably used in A1). 0068. In A2), polymeric polyols with a number-average molecular weight M of preferably 400 to 8000 g/mol, more preferably from 400 to 6000 g/mol and particularly prefer ably from 600 to 3000 g/mol are used. These preferably have an OH functionality of from 1.5 to 6, particularly preferably from 1.8 to 3, very particularly preferably from 1.9 to 2.1. 0069. The expression "polymeric' polyols means here in particular that the specified polyols have at least two, more preferably at least three, repeat units joined together. 0071. The preferably used polyester polyols are the poly condensates known perse of di-and optionally tri-and tetra ols and di-and optionally tri-and tetracarboxylic acids or hydroxycarboxylic acids or lactones. Instead of the free poly carboxylic acids, it is also possible to use the corresponding polycarboxylic acid anhydrides or corresponding polycar boxylic acid esters of lower alcohols for the preparation of the polyesters. I0087 Particularly preferred components in A2) are poly tetramethylene glycol polyethers and polycarbonate polyols and mixtures thereof and particularly preferably polytetram ethylene glycol polyethers. I0088. In preferred embodiments of the invention, compo nent A2) is accordingly: 0089 mixtures comprising at least one polyether polyol and at least one polycarbonate polyol. 0090 mixtures comprising more than one polyether polyol, or a mixture of two or more polyether polyols with different molecular weights, which are in particular poly(tetramethylene glycol) polyether polyols (such as HO-(CH, CH, CH, CH, O), H), 0.091 mixtures comprising more than one polyether polyol and at least one polycarbonate polyol, and also 0092 particularly preferably polyester polyols with a number-average molecular weight of from 600 to 3000 g/mol, in particular aliphatic polyester polyols based on aliphatic carboxylic acids and aliphatic polyols, in par ticular based on adipic acid and aliphatic alcohols, such as hexanediol and/or neopentylglycol, where component A), according to the definition, has neither ionic nor ionogenic groups. 0093. As component A3), polyols, in particular nonpoly meric polyols, of the specified preferred molecular weight range from 66 to 399 mol/g with up to 20 carbon atoms, such as ethylene glycol, diethylene glycol, triethylene glycol, 1.2-propanediol. 1,3-propanediol, 1,4-butanediol. 1,3-butylene glycol, cyclohexanediol. 1.4-cyclohexanedimethanol, 1.6-hexanediol, neopentylglycol, hydroquinone dihydroxyethyl ether, bisphenol A (2.2-bis(4-hydroxyphenyl)propane), hydrogenated bisphenol A (2.2-bis(4-hydroxycyclohexyl) propane), trimethylolpropane, trimethylolethane, glycerol, pentaerythritol and any desired mixtures thereof, can be used as desired.
0094. Also suitable are esterdiols of the specified molecu lar weight range. Such as C.-hydroxybutyl e-hydroxycaproic acid ester, co-hydroxyhexyl Y-hydroxybutyric acid ester, adi pic acid (B-hydroxyethyl) ester or terephthalic acid bis(Bhydroxyethyl) ester. 0095. In addition, as component A3), it is also possible to use monofunctional isocyanate-reactive hydroxyl-group containing compounds. Examples of Such monofunctional compounds are ethanol, n-butanol, ethylene glycol monobu tyl ether, diethylene glycol monomethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, dipropylene glycol monomethyl ether, tripropylene glycol monomethyl ether, dipropylene glycol monopropyl ether, propylene glycol monobutyl ether, dipropylene glycol monobutyl ether, tripropylene glycol monobutyl ether, 2-eth ylhexanol, 1-octanol. 1-dodecanol, 1-hexadecanol. 0096. In one preferred embodiment of the invention, the polyurethane used according to the invention comprises less than about 10% by weight of component A3), preferably less than 5% by weight of component A3), in each case based on the total mass of the polyurethane, yet more preferably com ponent A3) is not used for the preparation of the polyurethane. 0097. To prepare the polyurethanes used according to the invention, one or more in particular isocyanate-reactive non ionic hydrophilizing agents are optionally used as component A4). The hydrophilizing agents used as component A4) are in particular different from components A2) and A3). 0098 Suitable nonionically hydrophilizing compounds as component A4) are, for example, polyoxyalkylene ethers which have isocyanate-reactive groups, such as hydroxy, amino or thiol groups. Preference is given to monohydroxy functional polyalkylene oxide polyether alcohols having, on statistical average, 5 to 70, preferably 7 to 55, ethylene oxide units per molecule, as are accessible in a manner known perse by alkoxylation of suitable starter molecules (e.g. in Ull manns Encyclopadie der technischen Chemie Ullmanns encyclopaedia of industrial chemistry, 4th edition, Volume 19, Verlag Chemie, Weinheim pp. 31-38). These are either pure polyethylene oxide ethers or mixed polyalkylene oxide ethers, where they contain at least 30 mol %, preferably at least 40 mol %, ethylene oxide units, based on all of the alkylene oxide units present. 0099 Particularly preferred nonionic compounds are monofunctional mixed polyalkylene oxide polyethers which have 40 to 100 mol% ethylene oxide units and 0 to 60 mol% propylene oxide units. 0100 Suitable starter molecules for such nonionic hydro philizing agents are in particular Saturated monoalcohols, Such as methanol, ethanol, n-propanol, isopropanol, n-bu tanol, isobutanol, sec-butanol, the isomeric pentanols, hex anols, octanols and nonanols, n-decanol, n-dodecanol, n-tet radecanol, nhexadecanol, n-octadecanol, cyclohexanol, the isomeric methylcyclohexanols or hydroxymethylcyclohex ane, 3-ethyl-3-hydroxymethyloxetane or tetrahydrofurfuryl alcohol, diethylene glycol monoalkyl ethers, such as, for example, diethylene glycol monobutyl ether, unsaturated alcohols, such as allyl alcohol, 1,1-dimethylallyl alcohol or oleyl alcohol, aromatic alcohols, such as phenol, the isomeric cresols or methoxyphenols, araliphatic alcohols, such as ben Zyl alcohol, anisyl alcohol or cinnamyl alcohol, secondary monoamines. Such as dimethylamine, diethylamine, dipropy lamine, diisopropylamine, dibutylamine, bis(2-ethylhexyl) amine, N-methyl-and N-ethylcyclohexylamine or dicyclo hexylamine, and also heterocyclic secondary amines, such as morpholine, pyrrolidine, piperidine or 1H-pyrazole. Pre ferred starter molecules are saturated monoalcohols of the type specified above. Particular preference is given to using diethylene glycol monobutyl ether or n-butanol as starter molecules. Mar. 19, 2015 0101 Alkylene oxides suitable for the alkoxylation reac tion are in particular ethylene oxide and propylene oxide, which can be used in the alkoxylation reaction in any desired order or else in a mixture.
0102 Component B) is preferably selected from primary or secondary amine and/or diamines. It includes in particular diamines.
0103) As component B) it is possible to use in particular amines which have no ionic or ionogenic, such as anionically hydrophilizing groups (component B1) below), and it is pos sible to use amines which have ionic or ionogenic, such as, in particular, anionically hydrophilizing groups (component B2) below). Preferably, in step B) of the reaction of the prepolymer, a mixture of component B1) and of component B2) is reacted. 0104 For example, organic di-or polyamines, such as, for example, 1.2-ethylenediamine, 1.2-and 1,3-diaminopro pane, 1,4-diaminobutane, 1,6-diaminohexane, isophoronedi amine, isomer mixture of 2.2.4-and 2,4,4-trimethylhexam ethylenediamine, 2-methylpentamethylenediamine, diethylenetriamine, 4,4-diaminodicyclohexylmethane, hydrazine hydrate, and/or dimethylethylenediamine, can be used as component B1). 0105 Moreover, compounds which, besides a primary amino group, also have secondary amino groups or, besides anamino group (primary or secondary), also have OH groups, can also be used as component B1). Examples thereof are primary/secondary amines, such as diethanolamine, 3-amino-1 methylaminopropane, 3-amino-1-ethylaminopro pane, 3-amino-1-cyclohexylaminopropane, 3-amino-1-me thylaminobutane, alkanolamines. Such as N-aminoethyletha nolamine, ethanolamine, 3-aminopropanol, neopentanolamine. 0106. In addition, monofunctional isocyanate-reactive amine compounds can also be used as component B1). Such as, for example, methylamine, ethylamine, propylamine, butylamine, octylamine, laurylamine, Stearylamine, isonony loxypropylamine, dimethylamine, diethylamine, dipropy lamine, dibutylamine, N-methylaminopropylamine, diethyl (methyl)aminopropylamine, morpholine, piperidine, and suitable substituted derivatives thereof, amidoamines of diprimary amines and monocarboxylic acids, monoketime of diprimary amines, primary/tertiary amines. Such as N,N-dim ethylaminopropylamine. 0107 As component B1), preference is given to using 1.2-ethylenediamine, bis(4-aminocyclohexyl)methane, 1,4-diaminobutane, isophoronediamine, ethanolamine, diethano lamine and diethylenetriamine. 0.108 Component B) particularly preferably includes at least one component B2). Suitable anionically hydrophilizing compounds as component B2) preferably contain a Sulphonic acid or Sulphonate group, particularly preferably a sodium Sulphonate group. Suitable anionically hydrophilizing com pounds as component B2) are, in particular, the alkali metal salts of mono-and diaminosulphonic acids. Examples of Such anionic hydrophilizing agents are salts of 2-(2-aminoethy lamino)ethanesulphonic acid, ethylenediaminepropyl-or -butylsulphonic acid, 1.2-or 1,3-propylenediamine-B-ethyl sulphonic acid or taurine. Furthermore, the salt of cyclohexy laminopropanesulphonic acid (CAPS) from WO-A 01/88006 can be used as anionic hydrophilizing agent. 0109 Particularly preferred anionic hydrophilizing agents B2) are those which contain Sulphonate groups as ionic groups and two amino groups, such as the salts of 2-(2-aminoethylamino)ethylsulphonic acid and 1,3-propylenedi amine-B-ethylsulphonic acid. 0110. The polyurethanes used according to the invention particularly preferably comprise at least one Sulphonate group.
0111 Optionally, the anionic group in component B2) may also be a carboxylate or carboxylic acid group. Compo nent B2) is then preferably selected from diaminocarboxylic acids. However, this embodiment is less preferred since car boxylic-acid-based components B2) have to be used in higher concentrations.
0112 For the hydrophilization, it is also possible to use mixtures of anionic hydrophilizing agents B2) and nonionic hydrophilizing agents A4). 0113. In a preferred embodiment for the preparation of the special polyurethane dispersions, components A1) to A4) and B1) to B2) are used in the following amounts, the individual amounts always adding up to 100% by weight: 5 to 40% by weight of component A1), 55 to 90% by weight of A2), 0.5 to 20% by weight sum of components A3) and/or B1). 0.1 to 25% by weight sum of components A4) and/or B2), where, based on the total amounts of components A1) to A4) and B1) to B2), particularly preferably 0.1 to 5% by weight of anionic or potentially anionic hydrophilizing agents B2) are used.
0114. In a particularly preferred embodiment for the preparation of the special polyurethane dispersions, compo nents A1) to A4) and B1) to B2) are used in the following amounts, the individual amounts always adding up to 100% by weight: 5 to 35% by weight of component A1), 60 to 90% by weight of A2), 0.5 to 15% by weight sum of components A3) and/or B1). 0.1 to 15% by weight sum of components A4) and/or B2), where, based on the total amounts of components A1) to A4) and B1) to B2), particularly preferably 0.2 to 4% by weight of anionic or potentially anionic hydrophilizing agents B2) are used. 0115. In a very particularly preferred embodiment for the preparation of the special polyurethane dispersions, compo nents A1) to A4) and B1) to B2) are used in the following amounts, the individual amounts always adding up to 100% by weight: 10 to 30% by weight of component A1), 65 to 85% by weight of A2), 0.5 to 14% by weight sum of components A3 and/or B1). 0.1 to 13.5% by weight sum of components A4) and/or B2), where, based on the total amounts of components A1) to A4) and B1) to B2, particularly preferably 0.5 to 3.0% by weight of anionic or potentially anionic hydrophilizing agents from B2) are used. 0116. The preparation of the polyurethane dispersions can be carried out in one or more stage(s) in homogeneous phase or, in the case of multistage reaction, sometimes in disperse phase. Following complete or partial polyaddition from A1) to A4), a dispersion, emulsification or dissolution step pref erably takes place. Afterwards, a further polyaddition or modification optionally takes place in the disperse phase. 0117. In this connection, all of the methods known from the prior art, such as, for example, prepolymer mixing pro cess, acetone process or melt dispersion process, can be used. Preference is given to using the acetone process. Mar. 19, 2015 0118 For the preparation in accordance with the acetone process, constituents A2) to A4) and the polyisocyanate com ponent A1) for the preparation of an isocyanate-functional polyurethane prepolymer are usually initially introduced in their entirety or in part and optionally diluted with a solvent which is miscible with water but inert towards isocyanate groups, and heated to temperatures in the range from 50 to 120° C. To increase the rate of the isocyanate addition reac tion, the catalysts known in polyurethane chemistry can be used.
0119 Suitable solvents are the customary aliphatic, keto functional solvents such as acetone, 2-butanone, which can be added not only at the start of the preparation, but optionally in parts also later on. Preference is given to acetone and 2-bu tanone, and particular preference is given to acetone. The addition of other solvents without isocyanate-reactive groups is also possible, but not preferred. I0120 Any constituents of A1) to A4) not added at the start of the reaction are then metered in.
I0121. During the preparation of the polyurethane prepoly mer from A1) to A4), the quantitative ratio of isocyanate groups to isocyanate-reactive groups is generally 1.05 to 3.5. preferably 1.1 to 3.0, particularly preferably 1.1 to 2.5. 0.122 The reaction of components A1) to A4) to give the prepolymertakes place partially or completely, but preferably completely. Polyurethane prepolymers which contain free isocyanate groups are thus obtained without a diluent or in Solution.
(0123. In the neutralization step for the partial or complete conversion of potentially anionic groups to anionic groups, bases such as tertiary amines, e.g. trialkylamines having 1 to 12, preferably 1 to 6, carbon atoms, particularly preferably 2 to 3 carbon atoms in each alkyl radical or very particularly preferably alkali metal bases such as the corresponding hydroxides are used. 0.124. The use of organic amines is not preferred. 0.125 Neutralizing agents which can be used are prefer ably inorganic bases, such as aqueous ammonia Solution or Sodium hydroxide or potassium hydroxide. 0.126 Preference is given to sodium hydroxide and potas sium hydroxide. I0127. The quantitative amount of the bases is 50 and 125 mol %, preferably between 70 and 100 mol % of the quanti tative amount of the acid groups to be neutralized. The neu tralization can also take place at the same time as the disper sion by the dispersion water already comprising the neutralizing agent. I0128. Afterwards, in a further process step, in cases where it has still not happened or has only happened partially, the resulting prepolymer is dissolved with the help of aliphatic ketones such as acetone or 2-butanone.
I0129. The reaction of components A1) to A4) to give the prepolymertakes place partially or completely, but preferably completely. In this way, polyurethane prepolymers which contain free isocyanate groups are obtained without a diluent or in Solution.
0.130. During the chain extension in stage B), NH-and/or NH-functional components are reacted with the remaining isocyanate groups of the prepolymer. Preferably, the chain extension/termination is carried out prior to the dispersion in Water. I0131 Suitable components B) for the chain extension are, in particular, organic di-or polyamines B1). Such as, for example, ethylenediamine, 1.2-and 1,3-diaminopropane, 1,4-diaminobutane, 1,6-diaminohexane, isophoronediamine, isomer mixture of 2.2.4-and 2,4,4-trimethylhexamethylene diamine, 2-methylpentamethylenediamine, diethylenetri amine, diaminodicyclohexylmethane and/or dimethylethyl enediamine.
0132 Moreover, it is also possible to use compounds B1) which, besides a primary amino group, also have secondary amino groups or, besides an amino group (primary or second ary), also have OH groups. Examples thereof are primary/ secondary amines, such as diethanolamine, 3-amino-1 methylaminopropane, 3-amino-1-ethylaminopropane, 3-amino-1-cyclohexylaminopropane, 3-amino-1-methy laminobutane, alkanolamines, such as N-aminoethylethano lamine, ethanolamine, 3-aminopropanol, neopentanolamine for the chain extension and/or termination.
0.133 For the chain termination, use is usually made of amines B1) having a group which is reactive towards isocy anates, such as methylamine, ethylamine, propylamine, buty lamine, octylamine, laurylamine, Stearylamine, isononylox ypropylamine, dimethylamine, diethylamine, dipropylamine, dibutylamine, N-methylaminopropylamine, diethyl(methyl)aminopropylamine, morpholine, piperidine, and suitable substituted derivatives thereof, amidoamines of diprimary amines and monocarboxylic acids, monoketime of diprimary amines, primary/tertiary amines. Such as N,N-dim ethylaminopropylamine. 0134. If anionic hydrophilizing agents corresponding to the definition of B2) with NH, or NH groups are used for the chain extension, the chain extension of the prepolymers pref erably takes place before the dispersion. 0135 The degree of chain extension, i.e. the equivalent ratio of NCO-reactive groups of the compounds used for the chain extension and chain termination to free NCO groups of the prepolymer is generally between 40 and 150%, preferably between 50 and 110%, particularly preferably between 60 and 100%.
0136. The aminic components B1) and B2) can optionally be used in water-or solvent-diluted form in the process according to the invention individually or in mixtures, with any order of the addition being possible in principle. 0.137 If water or organic solvents are co-used as diluents, then the diluent content in the component used in B) for chain extension is preferably 40 to 95% by weight. 0.138. The dispersion preferably takes place after the chain extension. For this, the dissolved and chain-extended poly urethane polymer is optionally either introduced into the dis persion water with strong shear, such as, for example, with vigorous stirring, or, conversely, the dispersion water is stirred into the chain-extended polyurethane polymer Solu tions. Preferably, the water is added to the dissolved chain extended polyurethane polymer. 0.139. The solvent still present in the dispersions after the dispersion step is then usually removed by distillation. Removal during dispersion is likewise possible. 0140. The residual content of organic solvents in the poly urethane dispersions prepared in this way is typically less than 10% by weight, preferably less than 3% by weight, based on the total dispersion. 0141. The pH of the aqueous polyurethane dispersions used according to the invention is typically less than 8.0, preferably less than 7.5 and is particularly preferably between 5.5 and 7.5.
0142. The cosmetic composition according to the inven tion comprises preferably 0.1 to 20% by weight of the poly Mar. 19, 2015 urethane described above and in particular 0.5 to 10% by weight, in each case based on the total weight of the compo sition.
0143. The cosmetic composition according to the inven tion comprises preferably 0.1 to 10% by weight more prefer ably 0.1 to 5% by weight and even more preferably 0.5 to 5% by weight of salicylic acid, in each case based on the total weight of the composition 0144. In another embodiment, the presently claimed invention relates to a personal care product comprising at least one inventively claimed composition. In another embodiment, the presently claimed invention relates to a medical product comprising at least one inventively claimed composition. 0145 Preferably the personal care product is selected from the group consisting of body sprays, deodorant prod ucts, detersive products, skin care products, hair care prod ucts, shaving compositions and personal cleansing products. 0146 Within the context of the present invention, the cos metic compositions can advantageoulsy skin cosmetic or hair cosmetic compositions.
Skin Cosmetic Composition 0147
The composition according to the invention which comprises the polyurethane described above or its aqueous dispersion should satisfy the aforementioned properties of a skincare product. A skin cosmetic composition is defined as a cosmetic composition for the cleansing, care and protection of the skin. Within the context of the present invention, skin cosmetic compositions are skincare product, Sunscreen com position, afterSun preparations, self-tarming compositions, decorative cosmetic, washing, showering and bathing prepa rations for use on the skin, face toners, face masks, insect repellent preparations, footcare compositions, shaving com positions, hair removal compositions, intimate care compo sitions, babycare compositions, deodorants and antiperspi rants. Preferred skin cosmetic compositions within the context of the present invention are skincare products. 0.148. Within the context of the present invention, the skin cosmetic compositions are differentiated in particular accord ing to their consistency: cream (viscous), lotion and milk (flowable), gels (semisolid), oils, and also balm and aqueous Solutions (liquid). Depending on their formulation, the com positions according to the invention can be used, for example, as face cream, day or night cream, body lotion, face cleanser etc. It is in Some instances possible that the compositions according to the invention are used as pharmaceutically active product, or comprise pharmaceutically active ingredients. 014.9 The skin cosmetic compositions may be present, for example, in the form of an aqueous or aqueous-alcoholic Solution, oil-in-water, silicone-in-water, water-in-oil, water in-silicone emulsion, multiple emulsion, Such as, oil-in-wa ter-in-oil, water-in-oil-in-water emulsion, polymer stabilized emulsion (so called hydrodispersion), Solids satbilized emul sion (also called pickering emulsion), PIT emulsion Hair Cosmetic Composition 0150. Within the context of the present invention, cos metic compositions hair cosmetic compositions selected from the group consisting of neutralizers for permanent waves, curl relaxers, styling wrap lotion, hair setting compo sition, hair shaping composition, hair colourant, hair treat ments and shampoo.
0151. The hair cosmetic compositions according to the invention comprise at least one component which is selected from the group consisting of conditioners, film formers and Surfactants, and optionally further cosmetic and/or dermato logical active ingredients, auxiliaries and Supplement. 0152 The cosmetic composition can also be foamed using a propellant gas. (R)331) , and also synthetic, semisynthetic and natural mixtures of Such esters, e.g. jojoba oil. c) alkylbenzoates C12-15-alkylbenzoate (Finsoly(RTN from Finetex) or 2-phenylethylbenzoate (X-TendR 226 from ISP) d) lecithins and the fatty acid triglycerides, namely the trig lycerol esters of Saturated and/or unsaturated, branched and/ or unbranched alkanecarboxylic acids of chain length from 8 to 24, in particular 12 to 18 carbon atoms. For example, the fatty acid triglycerides can be selected from the group of cocoglyceride, olive oil, Sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grapeseed oil, safflower oil, evening primrose oil, macadamia nut oil, apricot kernel oil, avocado oil and the like. e) dialkyl ethers and dialkyl carbonates, e.g. dicaprylyl ether (Cetiol ROE from Cognis) and/or dicaprylyl carbonate (for example Cetiol RCC from Cognis) are advantageous f) Saturated or unsaturated, branched or unbranched alcohols, Such as, for example, octyldodecanol. 0.192 The non-volatile oil can likewise advantageously also be a nonpolar oil which is selected from the group of branched and unbranched hydrocarbons, in particular min eral oil, Vaseline oil, paraffin oil, squalane and squalene, polyolefins, for example polydecenes, hydrogenated poly isobutenes, C13-16 isoparaffin and isohexadecane. 0193 The nonpolar non-volatile oil can be selected among the non-volatile silicone oils. 0194 Of the non-volatile silicone oils, the polydimethyl siloxanes (PDMS), which are optionally phenylated, such as phenyltrimethicone, or are optionally substituted with ali phatic and/or aromatic groups or with functional groups, for example hydroxyl groups, thiol groups and/or amino groups; polysiloxanes modified with fatty acids, fatty alcohols or polyoxyalkylenes and mixtures thereof can be given. The wax is advantageously selected from the groups of natural waxes, such as, for example, cotton wax, carnauba wax, candelilla wax, esparto wax, Japan wax, Montan wax, Sugarcane wax, beeswax, wool wax, shellac, microwaxes, ceresine, oZokerite, ouricury wax, cork fibre wax, lignite waxes, berry wax, shea butter or synthetic waxes, such as paraffin waxes, polyethylene waxes, waxes produced by Fis cher-Tropsch synthesis, hydrogenated oils, fatty acid esters and glycerides which are solid at 25°C., silicone waxes and derivatives (alkyl derivatives, alkoxy derivatives, and/or esters of polymethylsiloxane) and mixtures thereof. The waxes can be present in the form of stable dispersions of colloidal wax particles which can be prepared by known processes, for example as in "Microemulsions Theory and Practice', L.M. Prince Ed., Academic Press (1977), pages 21-32. (0199 Waxes may be present in amounts of from 0 to 10% by weight, based on the total weight of the composition, and preferably 0 to 5% by weight. 0200. The cosmetic composition according to the inven tion can also comprise a volatile oil which is selected from the group of volatile hydrocarbon oils, siliconized oils or fluori nated oils.
0201 The volatile oil can be present in an amount of from 0 to 25% by weight, based on the total weight of the emulsion, preferably 0 to 20% by weight and even more preferably 0 to 15% by weight. 0202 Within the context of the present specification, a Volatile oil is an oil which, upon contact with the skin at room temperature and atmospheric pressure, evaporates in less than one hour. The Volatile oil is liquid at room temperature and, at room temperature and atmospheric pressure, has a vapour pressure of from 0.13 to 40 000 Pa (10 to 300 mm Hg), preferably 1.3 to 13 000 Pa (0.01 to 100 mmHg) and particu larly preferably 1.3 to 1300 Pa (0.01 to 10 mmHg) and a boiling point of from 150 to 260° C. and preferably 170 to 2500 C. 0203) A hydrocarbon oil is understood as meaning an oil which is formed from carbonatoms and hydrogen atoms and optionally oxygen atoms or nitrogen atoms and contains no silicon atoms or fluorine atoms, where it may also consist of carbon atoms and hydrogen atoms; however, it can also con tain ester groups, ether groups, amino groups or amide groups.
0204 A siliconized oil is understood as meaning an oil which contains at least one silicon atom and in particular Si-O groups.
A fluorinated oil is to be understood as meaning an
oil which contains at least one fluorine atom.
0206. The volatile hydrocarbon oil according to the inven tion can be selected from the hydrocarbon oils with a flash point of from 40 to 102°C., preferably 40 to 55° C. and even more preferably 40 to 50° C. 0207 For example, the volatile hydrocarbon oils are those with 8 to 16 carbon atoms and mixtures thereof, in particular branched Cs--alkanes, such as the isoalkanes (which are also referred to as isoparaffins) with 8 to 16 carbon atoms, isododecane, isodecane, isohexadecane and, for example, the oils which are supplied under the tradenames Isopars(R or Permetyls(R); and the branched C-esters, such as isohexyl neopentanoate and mixtures thereof. 0208. The volatile hydrocarbon oils such as isododecane, isodecane and isohexadecane are particularly advantageous. 0209. The volatile siliconized oil according to the inven tion can be selected from the siliconized oils with a flashpoint of from 40 to 102°C., preferably a flash point above 55° C. and at most 95° C. and particularly preferably in the range from 65 to 95°C.
0210 For example, the volatile siliconized oils are straight-chain or cyclic silicone oils having 2 to 7 silicon atoms, where these silicones optionally contain alkyl or alkoxy groups having 1 to 10 carbon atoms. 0219. Further advantageous amphoteric surfactants are N-alkylamino acids, for example aminopropylalkylgluta mide, alkylaminopropionic acid, Sodium alkylimidodipropi onate and lauroamphocarboxyglycinate. 0220 Advantageous active nonionic surfactants within the context of the present invention are alkanolamides, such as cocamides MEA/DEA/MIPA, esters which are formed by esterification of carboxylic acids with ethylene oxide, glyc eryl, sorbitan or other alcohols, ethers, for example ethoxy lated alcohols, ethoxylated lanoline, ethoxylated polysilox anes, propoxylated POE ethers, alkyl polyglycosides, such as lauryl glucoside, decyl glycoside and cocoglycoside, glyco sides with an HLB value of at least 20 (e.g. Belsil RSPG 128V from Wacker). 0221 Further advantageous nonionic Surfactants are alco hols and amine oxides, such as cocoamidopropylamine oxide.
0222 Among the alkyl ether Sulphates, preference is given in particular to Sodium alkyl ether Sulphates based on di-or triethoxylated lauryl and myristyl alcohol. They are signifi cantly Superior to the alkyl Sulphates with regard to the insen sitivity towards water hardness, the ability to be thickened, the solubility at low temperature and in particular the skin and mucosa compatibility. Lauryl ether Sulphate has better foam properties than myristyl ether sulphate, but is inferior to this in terms of mildness.
0223 Alkyl ether carboxylates are types of the mildest Surfactants in general, but exhibit poor foam and viscosity behaviour. They are often used in combination with alkyl ether Sulphates and amphoteric Surfactants. 0224 Sulphosuccinic acid esters (Sulphosuccinates) are mild and readily foaming Surfactants, but on account of their poor ability to be thickened, are preferably used only together with other anionic and amphoteric Surfactants and, on account of their low hydrolysis stability, are used preferably only in neutral or well buffered products. 0225. Amidopropylbetaines have excellent skin and eye mucosa compatibility. In combination with other surfactants, their mildness can be improved synergistically. Preference is given to the use of cocamidopropylbetaine. 0226 Amphoacetates/amphodiacetates have, as amphot eric Surfactants, very good skin and mucosa compatibility and can have a conditioning effect and/or increase the care effect of Supplements. Like the betaines, they are used for optimiz ing alkyl ether Sulphate formulations. Sodium cocoamphoac etate and disodium cocoamphodiacetate are most preferred. 0227. Alkyl polyglycosides are mild, have good universal properties, but are weakly foaming. For this reason, they are preferably used in combinations with anionic Surfactants. Solvents 0228. The cosmetic acceptable medium of the cosmetic composition according to the invention comprises water and optionally a cosmetically suitable water-miscible organic Sol Vent. 0229. The water used in the cosmetic composition accord ing to the invention may be a blossom water, pure deminer alized water, mineral water, thermal water and/or seawater.
0230. In the case of an O/W composition, the water frac tion can be in the range from 40 to 95% by weight, preferably in the range from 50 to 90% by weight, very particularly in the range from 60 to 80% by weight, based on the total weight of the composition. In the case of a W/O composition, the water fraction is in the range from 0 to 60% by weight, preferably in the range from 10 to 50% by weight, very preferably in the range from 30 to 50% by weight, based on the total weight of the composition. 0231. The preferred solvents are, for example, the ali phatic alcohols with C1-4 carbon atoms, such as ethanol and isopropanol; polyol and derivatives thereof. Such as propy lene glycol, dipropylene glycol, butylene-13 glycol, polypropylene glycol, glycol ethers such as alkyl (C1-4) ethers of mono-, di-or tripropylene glycol or mono-, di-or triethylene glycol, and mixtures thereof. 0232. The quantitative fraction of the solvent or solvents in the composition according to the invention can be, for example, in the range from 0 to 25% by weight and preferably 0 to 15% by weight, based on the total weight of the compo sition.
0233. The cosmetic composition according to the inven tion can additionally comprise additives which are customary in cosmetics. Such as antioxidants, photoprotective agents and/or other auxiliaries and additives, such as, for example, emulsifiers, interface-active Substances, antifoams, thicken ers, Surfactants, active ingredients, humectants, filler, UV filters, film formers, solvents, coalescing agents, aroma Sub stances, odour absorbers, perfumes, gel formers and/or other polymer dispersions, such as, for example, dispersions based on polyacrylates or polyurethane, pigments, dyes, flow agents and/or thixotropic agents, Suppleness agents, softeners, pre Mar. 19, 2015 servatives. The amounts of the various additives are known to the person skilled in the art for the range to be used and are, for example, in the range from 0 to 25% by weight, based on the total weight of the composition.
Sensory Additives 0234. The cosmetic composition according to the inven tion can also comprise sensory additives. Sensory additives are to be understood as meaning colourless or white, mineral or synthetic, lamellar, spherical or elongated inert particles or a nonparticulate sensory additive which, for example, further improve the sensory properties of the formulations and, for example, leave behind a velvety or silky skin feel. 0235. The sensory additives can be present in the compo sition according to the invention, for example, in an amount of from 0 to 10% by weight, based on the total weight of the composition, and preferably from 0 to 7%. 0236 Advantageous particulate sensory additives within the context of the present invention are talc, mica, silicon dioxide, kaolin, starch and derivatives thereof (for example tapioca starch, distarch phosphate, aluminium and sodium starch octenyl Succinate and the like), pyrogenic silica, pig ments which have neither primarily a UV-filter effect nor colouring effect (Such as e.g. boron nitride etc.), boron nitride, calcium carbonate, dicalcium phosphate, magnesium carbonate, magnesium hydrogencarbonate, hydroxyapatites, microcrystalline cellulose, powders of synthetic polymers, such as polyamides (for example the polymers available under the trade name "Nylon R"), polyethylene, poly-8-ala nine, polytetrafluoroethylene ("Teflon R"), polyacrylate, polyurethane, lauroyl-lysine, silicone resin (for example the polymers available under the trade name "Tospearl(R" from Kobo Products Inc.), hollow particles of polyvinylidene/acry lonitriles (Expancel(R) from Akzo Nobel) or hollow particles of silicon oxide (Silica Beads(R from MAPRECOS). 0237 Advantageous nonparticulate sensory additives can be selected from the group of dimethiconols (e.g. Dow Corn ing 1503 Fluid from Dow Corning Ltd.), silicone copolymers (e.g. divinyldimethicone/dimethicone copolymer, Dow Corning HMW 2220 from Dow Corning Ltd.) or silicone elasters (e.g. dimethicone crosspolymer, Dow Corning 9040 Silicone Elastomer Blend from Dow Corning Ltd.).
Sunscreen Filters 0238. The cosmetic composition according to the inven tion can optionally also comprise Sunscreen filters, where the total amount of the sunscreenfilter is 0% by weight to 30% by weight, 0% by weight to 20% by weight, particularly advan tageously 0% by weight to 10% by weight, based on the total weight of the composition according to the invention. The sunscreen filters (or UV filters) can in particular be selected from the organic filters, the physical filters and mixtures thereof.
0239. The composition according to the invention can comprise UV-A filters, UV-B filters or broadband filters. The UV filters used can be oil-soluble or water-soluble. The list of specified UV filters below is of course not limiting. 0240 Examples of the UV-B filters are: 0241 (1) salicylic acid derivatives, particularly homo menthyl salicylate, octyl salicylate and 4-isopropylben Zyl salicylate; 0242 (2) cinnamic acid derivatives, in particular 2-eth ylhexyl p-methoxycinnamate, which is available from Givaudan under the name Parsol MCXR) and isopentyl 4-methoxycinnamate; 0243 (3) liquid B.B'-diphenylacrylate derivatives, in particular 2-ethylhexyl C.f3'-diphenylacrylate or octoc rylene, which is available from BASF under the name UVINUL N539(R); 0244 (4) p-aminobenzoic acid derivatives, in particular 2-ethylhexyl 4-(dimethylamino)benzoate, amyl 4-(dim ethylamino)benzoate; 0245 (5) 3-benzylidenecamphor derivatives, in par ticular 3-(4-methylbenzylidene)camphor which is com mercially available from Merck under the name EUSO LEX 6300.R., 3-benzylidenecamphor,
benzylidenecamphor Sulphonic acid and polyacrylami domethylbenzylidenecamphor; 0246 (6) 2-phenylbenzimidazole-5-Sulphonic acid, which is available under the name EUSOLEX 232(R) from Merck; 0247 (7) 1,3,5-triazine derivatives, in particular: -2,4, 6-trisp-(2-ethylhexyl-1'-oxycarbonyl)anilino-1,3,5-triazine, which is supplied by BASF under the name UVINULT150R, and -dioctylbutamidotriazone, which is supplied by Sigma 3V under the name UVASORB 0251 (1) dibenzoylmethane derivatives, particularly 4-(t-butyl)-4'-methoxydibenzoylmethane, which is sup plied by Givaudan under the name PARSOL 1789R) and 1-phenyl-3-(4-isopropylphenyl)propane-1,3-dione; 0252 (2) benzene-1,4-di(3-methylidenecamphor-10 Sulphonic acid), optionally completely or partially neu tralized, commercially available under the name MEXORYL SXOR) from Chimex 0253 (3) hexyl 2-(4-diethylamino-2'-hydroxybenzoyl) benzoate (also aminobenzophenone); 0254 (4) silane derivatives or polyorganosiloxanes with benzophenone groups; 0255 (5) anthranilates, particularly menthyl anthra nilate, which is supplied by Symrise under the name NEO HELIOPAN MAR; 0256 (6) compounds which contain at least two ben Zoazolyl groups or at least one benzodiazolyl group per molecule, in particular 1,4-bis-benzimidazolylphe nylene-3,3',5,5'-tetrasulphonic acid and its salts, which are commercially available from Symrise: 0257 (7) silicon derivatives of benzimidazolylbenza Zoles, which are N-substituted, or of benzofuranylben Zazoles, in particular: -2-1-3-1,3,3,3-tetramethyl-1-(trimethylsilyl)oxydisiloxanylpropyl)-1H benzimidazol-2-ylbenzoxazole; -2-1-3-1,3,3,3-tetramethyl-1-(trimethylsilyl)oxydisiloxanylpropyl 1H-benzimidazol-2-ylbenzothiazole; -2-1-(3-trimethylsilanylpropyl)-1H-benzimidazol-2-yl) benzoxazole; 6-methoxy-11'-bis(3-trimethylsilanylpropyl)1H, 1H-2.2" dibenzimidazolylbenzoxazole; -2-1-(3-trimethylsila nylpropyl)-1H-benzimidazol-2-ylbenzothiazole; which are described in the patent application EP-A-1 028 120; 0258 (8) triazine derivatives, in particular 2.4-bis(5-1 (dimethylpropyl)benzoxazol-2-yl-(4-phenyl)imino-6-(2-ethylhexyl)imino-1,3,5-triazine, which is supplied by 3V under the name Uvasorb(RK2A; and 0259 (9) band filters, and also mixtures with physical filters. 0265 Of the physical filters, the sulphates of barium, oxides of titanium (titanium dioxide, amorphous or crystal line in the form of rutile and/or anatase), of zinc, of iron, of Zirconium, of cerium, silicon, manganese or mixtures thereof may be given. The metal oxides can be present in particle form with a size in the micrometre range or nanometre range (nanopigments). The average particle sizes for the nanopig ments are, for example, 5 to 100 nm. polymers which are formed during the copolymerization of a monomer derived trom a vinyl compound with carboxy group, such as, in particular, acrylic acid, methacrylic acid, maleic acid, a-chloroacrylic acid, and a basic monomer which is derived from a vinyl compound which is substituted and comprises at least one basic atom, Such as, in particular, dialkylaminoalkyl methacrylate and acrylate, dialkylami noalkylmethacrylamide and -acrylamide. Such compounds have been described in the U.S. Pat. No. 3, 836, 537. polymers with units which are derived from: a) at least one monomer which is selected from the acrylamides or meth acrylamides which are Substituted on the nitrogen atom with an alkyl group, b) at least one acidic comonomer which con tains one or more reactive carboxy groups, and c) at least one basic comonomer, Such as esters of acrylic acid and meth acrylic acid with primary, secondary, tertiary and quaternary amino Substituents and the quaternization product of dim ethylaminoethyl methacrylate with dimethyl sulphate or diethyl sulphate. 0278 N-substituted acrylamides or methacrylamides par ticularly preferred according to the invention are compounds whose alkyl groups contain2 to 12 carbonatoms, particularly N-ethylacrylamide, N-t-butylacrylamide, N-t-octylacryla mide, N-octylacrylamide, N-decylacrylamide, N-dodecy lacrylamide and the corresponding methacrylamides. 0279. The acidic comonomers are selected in particular from acrylic acid, methacrylic acid, crotonic acid, itaconic acid, maleic acid, fumaric acid and the alkyl monoesters having 1 to 4 carbon atoms of maleic acid, maleic anhydride, fumaric acid or fumaric anhydride. Mar. 19, 2015 0280 Preferred basic comonomers are aminoethyl meth acrylate, butylaminoethyl methacrylate, N,N-dimethylami noethyl methacrylate, N-t-butylaminoethylmethacrylate. 0281 Crosslinked and completely or partially acylated polyaminoamides which are derived from polyaminoamides of the following general formula: in which R is a divalent group which is derived from a satu rated dicarboxylic acid, an aliphatic mono-or dicarboxylic acid with ethylenic double bond, an ester of these acids with a lower alkanol having 1 to 6 carbonatoms or a group which is formed during the addition of one of these acids onto a bis primary or bis secondary amine, and Z is a group which is derived from a bisprimary, mono-or bis-secondary polyalky lenepolyamine, and preferably: a) in quantitative fractions of from 60 to 100 mol % the groups -NH (CH), NH where X=2 and p=2 or 3 or x=3 and p=2, where this group is derived from diethylenetriamine, triethylenetetramine or dipropylenetriamine; b) in quantitative fractions of from 0 to 40 mol % the group -NH (CH), NH in which X=2 and p=1, which is derived from ethylenediamine, or the group which originates from piperazine: c) in quantitative fractions of from 0 to 20 mol %, the group -H (CH), NH , which is derived from hexamethyl enediamine, where these polyaminoamides are crosslinked by addition of a bifunctional crosslinking agent which is selected from the epihalohydrins, diepoxides, dianhydrides and bis-unsaturated derivatives, in an amount of from 0.025 to 0.35 mol of crosslinking agent per amino group of the polyaminoamide and are acylated with acrylic acid, chloro acetic acid or an alkanesulphone or salts thereof. 0282. The saturated carboxylic acids are preferably selected from the acids having 6 to 10 carbon atoms, such as adipic acid, 2,2,4-trimethyladipic acid and 2.4.4,-trimethyla dipic acid. terephthalic acid; acids with ethylenic double bond. Such as, for example, acrylic acid, methacrylic acid and itaconic acid.
0283. The alkanesultones used in the acylation are prefer ably propanesultone or butanesultone, the salts of the acylat ing agents are preferably the Sodium salts or potassium salts. in which R is a polymerizable unsaturated group, such as acrylate, methacrylate, acrylamide or methacrylamide, y and Z are integers from 1 to 3, R and Rs are a hydrogen atom, methyl, ethyl or propyl R. and Rs area hydrogenatom oran alkyl group which is selected such that the sum of the carbon atoms Ra and Rs does not exceed 10.
Polymers with Zwitterionic units of the following or ethyl, R is a hydrogen atom or a lower C-alkyl group, Such as methyl or ethyl, R is a lower C-alkyl group. Such as methyl or ethyl or a group of the formula: -R N(R), where R is a group -CH2-CH2, -CH2-CH2-CH or -CH2-CH(CH)-and where R has the meanings given above. 0288 Polymers which can be formed during the N-car boxyalkylation of chitosan, such as N-carboxymethylchito san or N-carboxybutylchitosan. 0289 Amphoteric polymers of the type-D-X-D-X, which are selected from: a) polymers which are formed by the action of chloroacetic acid or sodium chloroacetate on compounds
in which D is the group 0290 And X is the symbols E or E', where E or E', which are identical or different, are a divalent group which is a straight-chain or branched alkylene group having up to 7 carbon atoms in the main chain which is present in unsubsti tuted form or is substituted by hydroxy groups and can con tain one or more oxygen atoms, nitrogen atoms or Sulphur atoms and 1 to 3 aromatic and/or heterocyclic rings; where the oxygenatoms, nitrogen atoms and Sulphur atoms are present in the form of the following groups: ether, thioether, sulphox ide, Sulphone, Sulphonium, alkylamine, alkenylamine, hydroxy, benzylamine, anline oxide, quatemary annnonium, amide, imide, alcohol, ester and/or urethane.
b) polymers of the formula -D-X-D-X, in which D is the group and X is the symbol E or E' and at least once E'; where E has the meanings given above and E is a divalent group which is a straight-chain or branched alkylene group having up to 7 carbon atoms in the main chain, which is present in unsub stituted fonnor is Substituted by one or more hydroxy groups and contains one or more nitrogenatoms, where the nitrogen atom is Substituted by an alkyl group which is optionally interrupted by an oxygen atom and obligatorily comprises one or more carboxy functions or one or more hydroxy func tions and is betainized through reaction with chloroacetic acid or sodium chloroacetate.
0291 Alkyl (Cs) vinyl ether/maleic anhydride copoly mers which in part are partially modified by semiamidation with an N,N-dialkylaminoalkylamine, such as N,N-dimethy laminopropylamine or an N,N-dialkylaminoalcohol. 0296. The present invention is illustrated by reference to examples, although these are not to be understood as being limiting. Unless stated otherwise, all of the quantitative data, fractions and percentages are based on the weight and the total amount or on the total weight of the compositions. EXAMPLES 0297. Unless noted otherwise, all of the analytical mea surements refer to measurements at temperatures of 23°C. 0298. The solid or solid-body contents are determined by heating a weighed sample at 125° C. to constant weight. At constant weight, the solid-body content is calculated by reweighing the sample. 0299. Unless expressly mentioned otherwise, NCO con tents were determined volumetrically in accordance with DIN-EN ISO 11909. 0300. The control on free NCO groups was carried out by means of IR spectroscopy (band at 2260 cm). 0301 These stated viscosities were determined by means of rotary viscometry in accordance with DIN 53019 at 23° C. using a rotary viscometer from Anton Paar Germany GmbH, Ostfildern, Germany. 0302) The average particle sizes (the number-average is given) of the polyurethane dispersions were determined fol lowing dilution with deionized water by means of laser cor relation spectroscopy (instrument: Malvern Zetasizer 1000, Malver Inst. Limited). Polyurethane Dispersion 2 0314. 450 g of PolyTHF(R) 1000 (component A2)) and 2100 g of PolyTHFR 2000 (component A2)) were heated to 70° C. Then, a mixture of 225.8g of hexamethylene diisocy anate (component A1)) and 298.4 g ofisophorone diisocyan ate (component A1)) was added and the mixture was stirred at 100-115° C. until the actual NCO value had dropped below the theoretical NCO value. The finished prepolymer was dis solved with 54.60 g of acetone at 50° C. and then a solution of 29.5 g of ethylenediamine (component B1)), 143.2 g of diaminosulphonate (component B2)) and 610 g of water was metered in. The after stirring time was 15 min. The mixture was then dispersed by adding 1880 g of water. The solvent was removed by distillation in vacuo and a storage-stable dispersion was obtained. 0315 Solids content: 56% 0316 Particle size (LCS): 276 mm 0317 Viscosity: 1000 mPas Example 3
Polyurethane Dispersion 3 0318 1649.0 g of a polyester of adipic acid, hexanediol and neopentyl glycol with an average molecular weight of 1700 g/mol (component A2)) were heated to 65° C. Then, 291.7 g of hexamethylene diisocyanate (component A1))
were added and the mixture was stirred at 100-115° C. until the actual NCO value had dropped below the theoretical NCO value. The finished prepolymer was dissolved with 3450 g of acetone at 50° C. and then a solution of 16.8g of ethylenedi amine (component B1)), 109.7 g of diaminosulphonate (com ponent B2)) and 425 g of water was metered in. The after stirring time was 15 min. The mixture was then dispersed by adding 1880 g of water. The solvent was removed by distil lation in vacuo and a storage-stable dispersion was obtained. Polyurethane Dispersion 4 0323 340 g of a polyester of adipic acid, hexanediol and neopentylglycol with an average molecular weight of 1700 g/mol (component A2)) were heated to 65°C. Then, 60.1 g of hexamethylene diisocyanate (component A1)) were added and the mixture was stirred at 105° C. until the actual NCO value had dropped below the theoretical NCO value. The finished prepolymer was dissolved with 711 g of acetone at 50° C. and then a solution of 2.1 g of ethylenediamine (com ponent B1)), 32.4 g of diaminosulphonate (component B2)) and 104.3 g of water was metered in. The after stirring time was 15 min. The mixture was then dispersed by adding 1880 g of water. The solvent was removed by distillation in vacuo and a storage-stable dispersion was obtained. 0324 Solids content: 40% 0325 Particle size (LCS): 198 nm. 0326 Viscosity: 700 mPas 0327 pH: 6.31
Example 5
Polyurethane Dispersion 5 0328 450 g of PolyTHF(R) 1000 (component A2)) and 2100 g of PolyTHFR 2000 (component A2)) were heated to 70° C. Then, a mixture of 225.8g of hexamethylene diisocy anate (component A1)) and 298.4 g ofisophorone diisocyan ate (component A1)) was added and the mixture was stirred at 100-115° C. until the actual NCO value had dropped below the theoretical NCO value. The finished prepolymer was dis solved with 54.60 g of acetone at 50° C. and then a solution of 351 g of diaminosulphonate (component B2)) and 610 g of water was metered in. The after stirring time was 15 min. The mixture was then dispersed by adding 1880 g of water. The Mar. 19, 2015 Solvent was removed by distillation in vacuo and a storage stable dispersion was obtained. 0335 Adjust the pH to 4.0-4.5 Study Design: 0336. The goal was to investigate the role of the polyure thane dispersion according to the invention in the treatment of acne. The influence of polyurethane dispersion according to the invention on efficacy of skincare products (formulation 2) was in vivo determined and compared to skincare product without a polyurethane dispersion (Formulation 1)
